Kidney transplant medication: promising monthly infusion trial in 2026

Kidney transplant patient receiving a monthly infusion in NHS hospital, kidney transplant medication

A new UCSF phase 2 trial offers early hope that kidney transplant medication could one day shift from a daily cocktail of tablets to a monthly infusion, with the potential to reduce side effects and protect the donor kidney for longer. We explain what the researchers found and what it could mean for kidney transplant patients in the UK.

Could a small skin patch from a donor help detect transplant rejection earlier?

MRIKPA article featured image

For anyone who has received a transplant, or who is waiting for one, the fear of rejection is something that stays with you. After the initial relief of receiving a new organ, the reality of long-term monitoring begins: regular blood tests, clinic visits, and sometimes invasive biopsies to check whether the body is accepting or […]